Comparative Anticoagulant Activity of Afghan, Indian, Chinese, and Transbaikal Mumiyo in a Rat Model
Boltabaeva Dilbarkhon Fayzirakhmanovna
Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology.
Keywords: Mumiyo, blood coagulation, Lee-White method, Natural compounds, Afghan mumiyo, Indian mumiyo, Chinese mumiyo, Transbaikal mumiyo, Traditional medicine.
Abstract
This study aimed to compare the anticoagulant effects of different regional types of mumiyo Afghan, Indian, Chinese, and Transbaikal on blood coagulation in vitro using the Lee-White method in a rat model.
Aqueous solutions of each mumiyo type were prepared at concentrations of 1, 2, 5, and 10 mg/mL. Whole blood samples were collected from healthy Wistar rats and exposed to the mumiyo solutions. Clotting times were measured using the Lee White method at 37°C. A control group with no mumiyo treatment was used for baseline comparison. Each test was conducted in triplicate.
Chinese mumiyo demonstrated minimal effect on clotting time, while Afghan, Indian, and Transbaikal mumiyo showed significant anticoagulant activity in a dose-dependent manner. At concentrations of 2–5 mg/mL, clotting times were prolonged by up to 9–30 minutes, with the most pronounced effect observed in Afghan mumiyo at 10 mg/mL (90 minutes).
References
References
1. Qi Z, Kelley E. The WHO Traditional Medicine Strategy 2014-2023: A perspective. Science. 2014;346:S5-S6.
2. “WHO Traditional Medicine Strategy 2014-2023”. World Health Organization Retrieved 2014-04-20. 2013.
3. Shahriari M, Zare F, Nimrouzi M. The Curative Role of Bitumen in Traditional Persian Medicine. Acta Med Hist Adriat. 2018;16(2):283-92.
4. Olivieri MF, Marzari F, Kesel AJ, Bonalume L, Saettini F. Pharmacology and psychiatry at the origins of Greek medicine: The myth of Melampus and the madness of the Proetides. J Hist Neurosci. 2017;26(2):193-215.
5. Shirbeigi L ZA, Naghizadeh A, Alizadeh Vaghasloo M. The Concept of Temperaments in Traditional Persian Medicine. Trad Integr Med. 2017;2(3):143-56.
6. Frolova N, Kiseleva L, Tatiana. Chemical composition of mumijo and methods for determining its authenticity and quality (a review). Pharma Chem J. 1996;30(8):543-7.
7. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res. 2007;21(5):401-5.
8. Verma A, Kumar N, Gupta L, Chaudhary S. Shilajitin Cancer Treatment: Probable Mode of Action. Int J Pharmaceutic Bio Arch. 2016;7(1):12-6.
9. Stohs SJ, Singh K, Das A, Roy S, Sen CK. 12-Energy and Health Benefits of Shilajit. In: Bagchi D, editor. Sustained Energy for Enhanced Human Functions and Activity. Academic Press; 2017. p. 187-204
10. Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of Shilajit by its isolated active constituents. Phytother Res. 1991;5(5):211-6
11. Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. Indian J Pharmacol. 2004;36(6):373-6.
12. Загрутдинов Ф.Ф., Мамадалиев Ш.И., Болтабоева Д.Ф. Влияние Среднеазиатских Видов Мумиё на диурез и натрий урез у Крыс. Open Herald: Periodical of Methodical Research. Volume 2, Issue 5, May, 2024, 12-14














